AHA Comments on Medicare Advantage Proposed Rule for Contract Years 2021 and 2022

The American Hospital Association appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ proposed regulation regarding policy and technical changes to Medicare Advantage and Part D prescription drug program for Contract Years 2021 and 2022. The proposed rule addresses a number of areas of importance to hospitals and health systems, including those that sponsor MA plans.

The AHA supports CMS’s efforts to provide plans with additional flexibilities to facilitate innovation under the MA program to meet the unique and complex needs of the Medicare population. We, however, have concerns regarding several proposals addressing network adequacy in the proposed rule.